These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6707802)

  • 1. Treatment of hyperargininemia with sodium benzoate and arginine-restricted diet.
    Qureshi IA; Letarte J; Ouellet R; Batshaw ML; Brusilow S
    J Pediatr; 1984 Mar; 104(3):473-6. PubMed ID: 6707802
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperargininemia: clinical course and treatment with sodium benzoate and phenylacetic acid.
    Mizutani N; Maehara M; Hayakawa C; Kato T; Watanabe K; Suzuki S
    Brain Dev; 1983; 5(6):555-63. PubMed ID: 6670711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium benzoate and arginine: alternative pathway therapy in inborn errors of urea synthesis.
    Batshaw ML
    Prog Clin Biol Res; 1983; 127():69-83. PubMed ID: 6889404
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of severe OTC deficiency.
    Brubakk AM; Teijema LL; Blom W; Berger R
    J Pediatr; 1982 Jun; 100(6):929-31. PubMed ID: 7086593
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion.
    Batshaw ML; Brusilow S; Waber L; Blom W; Brubakk AM; Burton BK; Cann HM; Kerr D; Mamunes P; Matalon R; Myerberg D; Schafer IA
    N Engl J Med; 1982 Jun; 306(23):1387-92. PubMed ID: 7078580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic benzoate therapy in a boy with partial ornithine transcarbamylase deficiency.
    Letarte J; Qureshi IA; Ouellet R; Godard M
    J Pediatr; 1985 May; 106(5):794-7. PubMed ID: 3998920
    [No Abstract]   [Full Text] [Related]  

  • 7. Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy.
    Marescau B; Qureshi IA; De Deyn P; Letarte J; Ryba R; Lowenthal A
    Clin Chim Acta; 1985 Feb; 146(1):21-7. PubMed ID: 3987036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hyperammonemia with sodium benzoate.
    Kodama H; Kamoshita S; Motokawa Y
    J Pediatr; 1983 Sep; 103(3):498. PubMed ID: 6886925
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective management of a child with neonatal citrullinemia.
    Melnyk AR; Matalon R; Henry BW; Zeller WP; Lange C
    J Pediatr; 1993 Jan; 122(1):96-8. PubMed ID: 8419623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excretion of hippuric acid during sodium benzoate therapy in patients with hyperglycinaemia or hyperammonaemia.
    Barshop BA; Breuer J; Holm J; Leslie J; Nyhan WL
    J Inherit Metab Dis; 1989; 12(1):72-9. PubMed ID: 2501586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of severe carbamyl phosphate synthetase I deficiency.
    Van de Bor M; Mooy P; van Zoeren D; Berger R; van Gelderen HH; Teijema HL
    Arch Dis Child; 1984 Dec; 59(12):1183-5. PubMed ID: 6524951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative pathway therapy for urea cycle disorders.
    Feillet F; Leonard JV
    J Inherit Metab Dis; 1998; 21 Suppl 1():101-11. PubMed ID: 9686348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term administration of sodium benzoate to a patient with partial ornithine carbamoyl transferase deficiency.
    Takeda E; Kuroda Y; Toshima K; Watanabe T; Naito E; Miyao M
    Clin Pediatr (Phila); 1983 Mar; 22(3):206-8. PubMed ID: 6825366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy.
    Marescau B; De Deyn PP; Lowenthal A; Qureshi IA; Antonozzi I; Bachmann C; Cederbaum SD; Cerone R; Chamoles N; Colombo JP
    Pediatr Res; 1990 Mar; 27(3):297-303. PubMed ID: 1690873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginase deficiency presenting with convulsions.
    Patel JS; van't Hoff WV; Leonard JV
    J Inherit Metab Dis; 1994; 17(2):254. PubMed ID: 7967487
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.
    Brusilow SW; Danney M; Waber LJ; Batshaw M; Burton B; Levitsky L; Roth K; McKeethren C; Ward J
    N Engl J Med; 1984 Jun; 310(25):1630-4. PubMed ID: 6427608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periodic hyperammonemia, hyperlysinemia, and homocitrullinuria associated with decreased argininosuccinate synthetase and arginase activities.
    Sogawa H; Oyanagi K; Nakao T
    Pediatr Res; 1977 Sep; 11(9 Pt 1):949-53. PubMed ID: 904980
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteration of urinary carnitine profile induced by benzoate administration.
    Sakuma T
    Arch Dis Child; 1991 Jul; 66(7):873-5. PubMed ID: 1863104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological deterioration in patients with urea cycle disorders under valproate therapy--a cause for concern.
    Sewell AC; Böhles HJ; Herwig J; Demirkol M
    Eur J Pediatr; 1995 Jul; 154(7):593-4. PubMed ID: 7556337
    [No Abstract]   [Full Text] [Related]  

  • 20. Lysinuric protein intolerance. Urinary amino acid excretion at 2 and 9 days of age.
    Candito M; Vianey-Saban C; Ferraci JP; Bébin B; Chazalette JP; Sebag F; Mathieu M; Chambon P
    J Inherit Metab Dis; 1994; 17(2):252-3. PubMed ID: 7967486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.